Crinetics Pharmaceuticals Announces Upcoming Presentations at ENDO 2018
Mar 12, 2018 20:06 pm UTC| Business
SAN DIEGO, March 12, 2018 -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced an oral presentation and two poster...
Coupa Software Reports Fourth Quarter & Full Year Fiscal 2018 Financial Results
Mar 12, 2018 20:05 pm UTC| Business
Record Quarterly Revenues of $53.8 million, up 41% year over year Cumulative Spend Under Management Reaches $680 Billion SAN MATEO, Calif., March 12, 2018 -- Coupa Software (NASDAQ:COUP), a leader in business spend...
Mar 12, 2018 20:05 pm UTC| Business
LOS ANGELES, March 12, 2018 -- Reed’s Inc. (NYSE American:REED), owner of the nation’s leading portfolio of handcrafted, all-natural beverages, today announced that it intends to issue its financial results for the...
Green Brick Partners, Inc. Reports Fourth Quarter and Full Year 2017 Results
Mar 12, 2018 20:05 pm UTC| Business
Fourth Quarter Pre-Tax Income of $17.2 million, up 25.5%; 2017 Pre-Tax Income of $53.9 million, up 38.1%;Fourth Quarter Revenue of $136.4 million, up 13.9%;2017 Revenue of $454.4 million, up 19.5%;Backlog of $151.5...
Stitch Fix Announces Second Quarter Fiscal 2018 Financial Results
Mar 12, 2018 20:05 pm UTC| Business
SAN FRANCISCO, March 12, 2018 -- Stitch Fix, Inc. (NASDAQ:SFIX), an online personal styling service, has released its financial results for its second quarter of fiscal year 2018 ended January 27, 2018 and posted a...
G1 Therapeutics Announces Closing of Offering of Common Stock
Mar 12, 2018 20:05 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., March 12, 2018 -- G1 Therapeutics, Inc. (Nasdaq:GTHX), a clinical-stage oncology company, today announced the closing of an underwritten public offering of 3,910,000 shares of its common...
Mar 12, 2018 20:05 pm UTC| Business
DUBLIN, Ireland, March 12, 2018 -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in the neuroscience...